NEI Research News

A new study indicates that it may be possible to accurately characterize complete neural networks by recording the activity of properly selected samples of 50 neurons or less - an alternative that is much easier to realize.

Using a new approach, MIT researchers scanned individuals’ brains as they looked at different images and were able to pinpoint, to the millisecond, when the brain recognizes and categorizes an object, and where these processes occur.

Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, Emory University researchers have discovered.

The National Institutes of Health is releasing funding opportunities to build a new arsenal of tools and technologies for unlocking the mysteries of the brain.

Dr. David Hubel, a founder of modern neuroscience who helped decipher how our brains perceive what our eyes see, passed away on Sunday, September 22. He was 87.

A class of proteins that controls visual system development in the young brain also appears to affect vulnerability to Alzheimer’s disease in the aging brain.

Anthony Movshon, Ph.D., an NEI grantee and director of New York University’s Center for Neural Science, has won the 2013 Karl Spencer Lashley Award from the American Philosophical Society (APS).

Three researchers supported in part by NEI have been elected to the National Academy of Sciences, a nonprofit organization that advises the U.S. government on matters of science and technology.

Nerve cells that normally are not light sensitive in the retinas of blind mice can respond to light when a green algae protein called channelrhodopsin-2 (ChR2) is inserted into the cell membranes according to a National Institutes of Health...

Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventually develop multiple sclerosis (MS).